Sort
64,565 grants matching “drug discovery”
Preclinical characterization of EMT/CSC-specific small molecule inhibitors for TNBCs
$519,217Sendurai Ayyavoo Mani · University Of Tx Md Anderson Can Ctr · R01 · FY2019 · CA
Discovery and Function of Higher-Order RNA Structure
$519,170Kevin M Weeks · Univ Of North Carolina Chapel Hill · R35 · FY2020 · GM
NATIONAL BIOMEDICAL COMPUTATION RESOURCE
$519,026Peter William Arzberger · University Of California, San Diego · P41 · FY2009 · RR
Molecular Basis for Lens Transparency
$519,007Hassane S McHaourab · Vanderbilt University · R01 · FY2023 · EY
Characterizing the serum metabolome in multiple sclerosis
$518,973Farren B. S. Briggs · Case Western Reserve University · R01 · FY2021 · NS
Scalable tools for the analysis of chemical compounds using graph-based querying
$518,950William Maxwell Lindstrom · Acelot, Inc. · R44 · FY2008 · MH
Digital Multiplexed Analysis of Circulating Nucleic Acids in Small-Volume Blood Specimens
$518,921Andrew Michael Smith · University Of Illinois At Urbana-Champaign · R01 · FY2023 · EB
MIXED NOP/MU COMPOUNDS AND THE INVOLVEMENT OF THEIR RECEPTORS IN ANALGESIA
$518,916Lawrence R Toll · Florida Atlantic University · R01 · FY2018 · DA
Brain and Related Studies in SIDS Infants
$518,888Hannah Chase Kinney · Harvard Medical School · P01 · FY2015 · HD
Inhibition of Bcl-xL by Targeted Degradation
$518,840Guangrong Zheng · University Of Florida · R01 · FY2020 · CA
Molecular pathogenetic mechanisms in CM-AVM
$518,808Philip D King · University Of Michigan At Ann Arbor · R01 · FY2021 · HL
Molecular pathogenetic mechanisms in CM-AVM
$518,808Philip D King · University Of Michigan At Ann Arbor · R01 · FY2022 · HL
Molecular pathogenetic mechanisms in CM-AVM
$518,808Philip D King · University Of Michigan At Ann Arbor · R01 · FY2023 · HL
Severe Asthma Clinical Studies Core
$518,769James F Chmiel · Indiana University Indianapolis · P01 · FY2025 · HL
Pharmacology and Pre-Clinical Toxicology
$518,727Diane E Heck · Univ Of Med/Dent Nj-R W Johnson Med Sch · U54 · FY2010 · AR
Permeability Barriers of Gram-negative Pathogens and Approaches to Bypass Them
$518,640Helen I. Zgurskaya · University Of Oklahoma · R01 · FY2017 · AI
Cerebral Microvascular Bioenergetics and Neurovascular Coupling
$518,633Prasad V Katakam · Tulane University Of Louisiana · R01 · FY2021 · NS
Targeted Multi-Spectral Dual Axes Confocal Imaging of In Vivo Molecular Expressio
$518,564Thomas D Wang · University Of Michigan At Ann Arbor · R01 · FY2010 · CA
Resolving ensemble averaged conformations by multi-temperature x-ray crystallography
$518,561James Solomon Fraser · University Of California, San Francisco · R01 · FY2020 · GM
Circadian and mitochondrial dysfunction in alcohol-related liver disease
$518,556Shannon Marie Bailey · University Of Alabama At Birmingham · R01 · FY2023 · AA
Advancing our Understanding of Rare Pediatric Liver Diseases
$518,514Kathleen Mary Loomes · Children'S Hosp Of Philadelphia · U01 · FY2022 · DK
Institute for Clinical and Translational Research
$518,498Daniel Ernest Ford · Johns Hopkins University · UL1 · FY2016 · TR
Metabolic Assessment of Anti-Microbial Susceptibility within One Cell Cycle
$518,480Ji-Xin Cheng · Boston University (Charles River Campus) · R01 · FY2022 · AI
Metabolic Assessment of Anti-Microbial Susceptibility within One Cell Cycle
$518,480Ji-Xin Cheng · Boston University (Charles River Campus) · R01 · FY2021 · AI
Targeting the orphan nuclear receptor LRH-1 with small molecules
$518,408Eric A Ortlund · Emory University · R01 · FY2024 · DK